Physician profile
Tu A Tran
NPI 1467466243
$4,558.48
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $700 · 2020: $769 · 2021: $1,383 · 2022: $1,024 · 2023: $620 · 2024: $62.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $682.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,489.28 | 2019-2023 | Trulance, Xifaxan |
| Gilead Sciences, INC. | $716.49 | 2019-2023 | |
| Abbvie INC. | $545.65 | 2020-2023 | Linzess, Viberzi, Creon |
| Ardelyx, INC. | $205.13 | 2022-2023 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $158.06 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $126.82 | 2019 | |
| Redhill Biopharma INC. | $102.69 | 2022-2023 | Talicia, Movantik, Aemcolo |
| Exact Sciences Corporation | $62.08 | 2024 | Cologuard Collection Kit |
| Intercept Pharmaceuticals, INC. | $54.48 | 2022-2023 | Ocaliva |
| Celgene Corporation | $51.46 | 2021 | |
| Evoke Pharma, INC. | $24.73 | 2023 | Gimoti |
| Shionogi INC | $21.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tu Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.